Rising Respiratory Disorders Fueling Growth In Inhalation CDMO Market Is Supporting Development Across The Inhalation CDMO Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Value Of The Inhalation CDMO Market Increase Between 2026 And 2030?

The inhalation CDMO market has experienced substantial growth in recent years. This market is projected to expand from $2.2 billion in 2025 to $2.35 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 6.4%. Historically, this growth can be attributed to the rising prevalence of asthma and COPD, an increasing demand for inhalation therapies, the growth of biologics and specialized drug formulations, continuous advancements in formulation technologies, and the growing trend of outsourcing by pharmaceutical companies.

The inhalation cdmo market is anticipated to experience substantial expansion over the upcoming years. Its valuation is projected to reach $3.03 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.6%. This projected growth during the forecast timeframe can be ascribed to several factors, including the proliferation of digital and smart inhalers, the rise of personalized medicine and precision therapy, heightened investment in inhalation cdmo infrastructure, the growing uptake of advanced manufacturing technologies, and increased partnerships between biotechnology companies and CDMOs. Key trends anticipated during the forecast period encompass the advancement of personalized inhalation therapies, sophisticated formulation and drug delivery methodologies, improvements in regulatory adherence and quality assurance, the broadening of contract manufacturing services for small and medium-sized enterprises, and the integration of smart inhalers with digital health monitoring systems.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13864&type=smp

What Core Drivers Are Transforming The Inhalation CDMO Market?

The escalating occurrence of respiratory ailments is anticipated to drive the expansion of the inhalation CDMO market in the future. These disorders encompass various medical conditions impacting the respiratory system, comprising the organs and structures crucial for respiration. Inhalation CDMOs play a crucial role in creating and producing treatments for respiratory conditions, leveraging their proficiency in drug formulation and lung delivery. They provide specialized knowledge, facilities, and assets to pharmaceutical firms aiming to introduce novel inhalation therapies. For example, data from December 2023, sourced from the US-based medical library, the National Library of Medicine, indicates that the worldwide incidence of chronic obstructive pulmonary disease (COPD) among individuals aged 25 and older is predicted to increase by 23% by 2050, potentially affecting nearly 600 million people. Consequently, the rising occurrence of respiratory conditions is fueling the expansion of the inhalation CDMO market.

What Key Segment Areas Are Included In The Inhalation CDMO Market Assessment?

The inhalation cdmo market covered in this report is segmented –

1) By Product: Dry Powder Inhaler (DPIs), Metered Dose Inhaler (MDIs), Nebulizer, Soft Mist Inhaler

2) By Disease Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension, Acute Respiratory Distress Syndrome, Pulmonary Fibrosis

3) By Technology: Manual Inhalers (SMI), Digital Inhalers

4) By End-User: Big Pharmaceutical Companies, Small and Medium-sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Dry Powder Inhaler (DPIs): Capsule-Based DPIs, Diskus-Style DPIs, Multi-Dose DPIs, Unit-Dose DPIs

2) By Metered Dose Inhaler (MDIs): Pressurized MDIs (pMDIs), Breath-Actuated MDIs, Soft Mist MDIs

3) By Nebulizer: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Portable Nebulizers

4) By Soft Mist Inhaler: Respimat Inhalers, Other Soft Mist Inhalation Devices

Which Trends Are Affecting The Inhalation CDMO Market Framework?

Major corporations within the inhalation CDMO industry are increasingly adopting a strategic partnership approach to deliver specialized drug development and delivery services. A strategic partnership is defined as a long-term, mutually beneficial agreement between two or more entities working together to achieve shared goals. For instance, in May 2023, Hovione, a Portugal-based Contract Development and Manufacturing Organization, formed a partnership with H&T Presspart, a UK-based manufacturer of high-precision metal and plastic components for the pharmaceutical industry, with the goal of developing Presspart’s Sunrise Capsule-based Dry Powder Inhaler platform. This collaboration is specifically focused on advancing new technologies that can facilitate the delivery of higher drug doses and enhance the efficiency of drug delivery to the lungs.

Which Organizations Are Operating Within The Inhalation CDMO Market?

Major companies operating in the inhalation cdmo market are Baxter’s BioPharma Solutions, Lonza Group AG, Catalent Inc., Siegfried Holding AG, Recipharm AB, Stevanato Group SpA, CordenPharma, Nemera, Hovione FarmaCiencia SA, Vectura Group Ltd., CARBOGEN AMCIS, Kindeva Drug Delivery Ltd., Frontage Laboratories Inc, Sanner GmbH, H&T Presspart Ltd., Astech Projects Ltd, Cliantha Research, Copley Scientific, Cambrex Corporation, AptarGroup Inc.

Access The Complete Inhalation CDMO Market Report:

https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report

Which Region Has The Strongest Presence In The Inhalation CDMO Market?

North America was the largest region in the inhalation contract development and manufacturing organization (CDMO) market in 2025. The regions covered in the inhalation cdmo market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Inhalation CDMO Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=13864&type=smp

Browse Through More Reports Similar to the Global Inhalation CDMO Market 2026, By The Business Research Company

Inhalation Cdmo Market Report 2026

https://www.thebusinessresearchcompany.com/report/inhalation-cdmo-global-market-report

Inhalable Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report

Inhalation Anesthesia Market Report 2026

https://www.thebusinessresearchcompany.com/report/inhalation-anesthesia-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795